Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Rat dog micro-cap picks... -- Ignore unavailable to you. Want to Upgrade?

To: D_I_R_T who wrote (4635)	2/12/2001 12:45:16 PM
From: Laura E.	Respond to of 48461

BSTI News Monday February 12, 12:31 pm Eastern Time Press Release SOURCE: BioShield Technologies, Inc. BioShield Technologies, Inc. Completes Successfully $500,000 In New Financing Despite Market Conditions Senior Management Agrees to No-Cash Compensation Until May 31st, 2001 ATLANTA, Feb. 12 /PRNewswire/ -- BioShield Technologies, Inc., (Nasdaq: BSTI - news) After raising $500,000 in the first round of a recent $1,000,000 private equity placement BioShield management announced it will not be necessary at this time to pursue the additional $500,000 requested in the offering. Management made this decision in part based on the increased level of orders for its products and after reviewing recent projections of near term capital needs. Management stated, ``This round of financing sets the stage for us to meet our short term initial working capital, marketing and core product delivery needs. We are delighted with the support shown by the loyal shareholders, investor community, our customers and strategic vendors.'' In addition the senior management of Bioshield overwhelmingly agreed to accept no cash compensation for their services until May 31st, 2001. Management commented on this by stating, ``We offer this and our recent agreement with Hong Kong based Megastar L.L.C. as a sign of the commitment management has to increasing shareholder value by controlling overhead and aggressively pursing sales worldwide. We have every intention of making 2001 an exciting year for the firm and its shareholders.'' By focusing on the Company's core business of anti-viral and antimicrobial products, Bioshield management feels the company has the ability to become one of the potentially dominant players in the EPA approved antimicrobial industry. The BioShield antimicrobial not only prevents the growth of bacteria, it also works against various strains of fungi (most common of which are mold and mildew) and algae. The final, and by far the most significant, advantage of the BioShield technology is not that it is able to prevent the growth a broad range of microorganisms that antibacterials cannot, it is that the BioShield technology is residual. This means that long after it is applied and has dried, it continues to work by preventing the re-growth of harmful microorganisms. Even the best disinfectants and sanitizers quit working as soon as they dry. Take, for example, bleach. Bleach is a trusted, commonly used household product for tough cleaning jobs. It's very effective in eliminating many types of microorganisms. However, bleach has two downfalls: it gives off noxious fumes and is highly toxic, and it quits working as soon as it dries. Within seconds, microorganisms begin to re-grow. Although these may not show to the eye for several weeks, they are present and can produce problematic odors. BioShield's antimicrobial currently has six EPA registrations and 3 patents. Our patents are available for review on the IBM Patent Server. Safe Harbor/Forward-looking Statements, etc